Related Experiment Video
Updated: Mar 12, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.9K
Dapagliflozin effect on pericardial fat deposition: lessons from the DAPA EAT
Alberto Palazzuoli1, Kaveh Hossein2,3,4, Parham Dastjerdi5
1Cardiovascular Diseases Unit, Cardio thoracic and vascular Department Le Scotte hospital Siena University of Siena, Siena, Italy. palazzuoli2@unisi.it.
Heart Failure Reviews
|March 10, 2026
Abstract
No abstract available in PubMed .
Related Concept Videos
01:23Dipeptidyl Peptidase 4 Inhibitors
836
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
836
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
342
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342